Browse EX-10 agreements

TERMINATION AGREEMENT

** **

This TERMINATION AGREEMENT (this “Termination Agreement”) is entered into as of July 15, 2026 (the “Termination Agreement Effective Date”), by and between Arbutus Biopharma Corporation, a British Columbia corporation (“Arbutus”), and Genevant Sciences GmbH, a limited liability company organized and existing under the laws of Switzerland (“Genevant”). Arbutus and Genevant may be referred to herein individually as a “Party” and together as the “Parties.”

RECITALS

WHEREAS, the Parties entered into that certain Agreement, dated as of March 2, 2025 (the “mRESVIA Agreement”), regarding the treatment of any recovery from Moderna, Inc. and its affiliates (together, “Moderna”) in the Parties’ patent infringement litigation against Moderna (as described more fully in the mRESVIA Agreement, the “Patent Litigation”) specifically allocated to Moderna’s vaccine marketed as mRESVIA®;

…

---

Exhibit 10.1

Execution Version

VOTING AND SUPPORT AGREEMENT

THIS VOTING AND SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of July 15, 2026, by and between Eli Lilly and Company, an Indiana corporation (“Parent”), and the undersigned holder (the “Stockholder”) of common stock, par value $0.01 per share, of AtaiBeckley Inc., a Delaware corporation (the “Company”, and such shares of common stock, the “Company Shares”). Capitalized terms used herein and not defined shall have the meanings ascribed to them in the Agreement and Plan of Merger, dated as of July 15, 2026 by and among Parent, Albali Acquisition Corporation, a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub”), and the Company (the “Merger Agreement”).

…

Certain identified information has been excluded from this exhibit both because it (i) is not material and (ii) is the type that the issuer treats as private or confidential. Brackets with triple asterisks denote omissions.

BRIDGE CREDIT AGREEMENT

Dated as of July 16, 2026

among

UBER TECHNOLOGIES, INC.,
as the Borrower,

MORGAN STANLEY SENIOR FUNDING, INC.,
as Administrative Agent,

and

The Other Lenders Party Hereto

MORGAN STANLEY SENIOR FUNDING, INC.,
BofA SECURITIES, INC. and
DEUTSCHE BANK SECURITIES INC.,
as
Joint Lead Arrangers and Joint Bookrunners

BofA SECURITIES, INC. and
DEUTSCHE BANK SECURITIES INC.
as Syndication Agents

TABLE OF CONTENTS

…

**FORM OF **

SECURITIES EXCHANGE AGREEMENT

This Securities Exchange Agreement** **(this “Agreement”), dated as of July 15, 2026 (the “Effective Date”), is entered into by and between ASP Isotopes Inc., a Delaware corporation (the “Company”), Quantum Leap Energy LLC, a Delaware limited liability company (“QLE”), and the person or entity identified on the signature page hereto (the “Holder”).

RECITALS

WHEREAS, the Company, QLE and the Holder are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), or Rule 506(b) of Regulation D (“Regulation D”) promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act;

…

FORM of Support AGREEMENT

This SUPPORT AGREEMENT (this “Agreement”) is made as of July 10, 2026, by and among INTERNATIONAL STEM CELL CORPORATION, a Delaware corporation (“Parent”), Lifeline Cell Technologies, LLC, California limited liability company (“Target”), AMERICAN TYPE CELL COLLECTION, INC., a District of Columbia corporation (“Purchaser”), and the Person set forth on Schedule A hereto ( “Stockholder”).

…

MEMBERSHIP INTEREST PURCHASE AGREEMENT

by and among

RON G. SCOTT, an individual and

PROGRESSIVE CARE, LLC, a Nevada Limited Liability Company

dated as of July 14, 2026

Exhibits

Exhibit A          Form of Noncompetition Agreement

Exhibit B          Form of Assignment of Membership Interests

Exhibit C          Form of Powers of Attorney

Exhibit D          Disclosure Schedules

MEMBERSHIP INTEREST PURCHASE AGREEMENT

THIS MEMBERSHIP INTEREST PURCHASE AGREEMENT (this “Agreement”) is entered into as of the 14th day of July, 2026 (the “Effective Date”) by and among PROGRESSIVE CARE, LLC, a Nevada limited liability company (the “Purchaser”), and RON G. SCOTT, an individual (the “Seller”) for the purchase of 100% of the membership interests in SCOTT’S PHARMACY, LLC, a Florida limited liability company (the "Company") (Purchaser and Seller are from time to time referred to individually as a “Party” and collectively as the “Parties”) as follows:

Background Statement

…

* *

SUBSCRIPTION AGREEMENT

THIS SUBSCRIPTION AGREEMENT (the “Agreement”) is dated as of July 9, 2026 by and between KSY Capital Investments, Inc of registered address 701 Karns Ct, North Wales, PA 19454 (the “Purchaser”), and Global AI, Inc. a Nevada corporation of registered address 110 Front Street, Suite 300, Jupiter, Florida 33477, (“Issuer). The Purchaser and Issuer, may hereinafter be referred to as the “Parties” and each, a “Party.”

WHEREAS, the Purchaser desires to subscribe for 250,000 shares of the Issuer’s Class A Common Stock, $0.001 (the “Shares”) from the Issuer, and Issuer desires to issue the Shares to the Purchaser in exchange for a purchase price of $2.00 per Share for a total purchase price of One Million One Hundred Thousand United States Dollars (USD $500,000.00) (the “Purchase Price”).

…

---

GAMESQUARE HOLDINGS, INC.

** **

OPTION AGREEMENT

This Option Agreement is entered into between GameSquare Holdings, Inc. (the “Company”) and the Optionee named below pursuant to the Incentive Plan of the Company (as may be amended or superseded, the “Plan”), and confirms that:

1. on **July 10, 2026 **(the “Grant Date”);

2. Justin Kenna (the “Optionee”);

3. was granted the option to purchase 1,195,712 common shares (the “Optioned Shares”) of the Company;

4. for the price of US$0.31 per Optioned Share (the “Exercise Price”);

5. exercisable from time to time after vesting up to, but not after, July 9, 2031; and

6. the Optioned Shares shall vest, on the terms and subject to the conditions set out in the Plan, on the following schedule:

	●	803,570 on the Grant Date

	●	392,142 on July 10, 2027

** **

…

---

** **

---

** **

Restricted Share Unit Grant

GameSquare Holdings, Inc.

** **

Grantee: Amaree Vichairattanawong

We are pleased to provide you with confirmation of a grant of restricted stock units (“RSUs”) under the GameSquare Holdings, Inc. (“GameSquare”) Incentive Plan (the “Incentive Plan”) in connection with your service to GameSquare as follows:

Restricted Share Unit Terms

Restricted Stock:	You have been granted 50,000 RSUs of GameSquare.
Grant Date:	July 10, 2026
Vesting Schedule:	The RSUs granted herein shall become vested as of the Grant Date.

…

GAMESQUARE HOLDINGS, INC.

** **

OPTION AGREEMENT

This Option Agreement is entered into between GameSquare Holdings, Inc. (the “Company”) and the Optionee named below pursuant to the Incentive Plan of the Company (as may be amended or superseded, the “Plan”), and confirms that:

1. on **July 10, 2026 **(the “Grant Date”);

2. Mike Munoz (the “Optionee”);

3. was granted the option to purchase 301,249 common shares (the “Optioned Shares”) of the Company;

4. for the price of US$0.31 per Optioned Share (the “Exercise Price”);

5. exercisable from time to time after vesting up to, but not after, July 9, 2031; and

6. the Optioned Shares shall vest, on the terms and subject to the conditions set out in the Plan, on the following schedule:

	●	188,280 on the Grant Date

	●	112,969 on July 10, 2027

** **

…

LAMB WESTON HOLDINGS, INC. 2026 INDUCEMENT STOCK PLAN (as Amended and Restated as of July 13, 2026) SECTION 1. NAME AND PURPOSE 1.1 Name. The name of the plan shall be the Lamb Weston Holdings, Inc. 2026 Inducement Stock Plan (the “Plan”). 1.2 Purpose of Plan. The purpose of the Plan is to provide awards as an inducement material to certain employees of the Company who are entering into employment with the Company or any of its Subsidiaries and to encourage stock ownership by such individuals, thereby aligning their interests with those of the Company’s stockholders. This Plan is intended to comply with Rule 303A.08 of the New York Stock Exchange Listed Company Manual, which provides an exception to the New York Stock Exchange’s shareholder approval requirement for the issuance of securities with respect to grants to employees of the Company as an inducement material to such individuals entering into employment with the Company, and shall be administered and interpreted consistent with such intent. SECTION 2. DEFINITIONS 2.1 Definitions. Whenever used herein, the following terms shal

…

VOTING SUPPORT AGREEMENT

THIS VOTING SUPPORT AGREEMENT, dated as of July __, 2026 (this “Agreement”), is entered into by and among the investors listed on the signature page hereto (collectivity, the “Investor”), and each of the individuals or entities listed on the signature pages hereto (each, a “Stockholder” and, together, the “Stockholders”).

RECITALS

**A. **Concurrently with the execution and delivery of this Agreement, Glucotrack, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”), is entering into that certain Securities Purchase Agreement, dated as of July 14, 2026, by and among the Company and the Investor (the “Purchase Agreement”), pursuant to which the Company will issue and sell to the Investor senior secured convertible promissory notes (collectively, the “Note”) and warrants to purchase shares of Common Stock (as defined in the Purchase Agreement) of the Company (the “Warrants”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Purchase Agreement.

…